What is UroGen Pharma's EV / sales?

UroGen Pharma (URGN) reported EV / sales of 6.9× in Q1 2026.

How has UroGen Pharma's EV / sales changed year-over-year?

UroGen Pharma's EV / sales increased by 18.3% year-over-year, from 5.8× to 6.9×.

What is the long-term trend for UroGen Pharma's EV / sales?

Over 5 years (2020 to 2025), UroGen Pharma's EV / sales has grown at a -19.5% compound annual growth rate (CAGR), from 30× to 10.2×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

UroGen Pharma URGN EV / sales

EV / sales at other companies

Bristol-Myers SquibbBMY

3.3×-0.1×

PfizerPFE

3.5×+0.3×

Johnson & JohnsonJNJ

6.5×+1.8×

Merck & Co.MRK

5.2×+1.2×

ImmunityBio, Inc.IBRX

57.9×-33.2×

CG OncologyCGON

1,121.8×-1,637×

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.73B+71.7%

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Calculated from UroGen Pharma’s reported figures.

enterprise value/total revenue=6.9×

Based on the most recent quarter.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's EV / sales?: UroGen Pharma (URGN) reported EV / sales of 6.9× in Q1 2026.
How has UroGen Pharma's EV / sales changed year-over-year?: UroGen Pharma's EV / sales increased by 18.3% year-over-year, from 5.8× to 6.9×.
What is the long-term trend for UroGen Pharma's EV / sales?: Over 5 years (2020 to 2025), UroGen Pharma's EV / sales has grown at a -19.5% compound annual growth rate (CAGR), from 30× to 10.2×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.